Mergers & Acquisitions - Biotechnology


Current filters:


Popular Filters

176 to 200 of 271 results

2012 again a bumper year for Pharma M&A, but values well down


The year 2012 was again a bumper year for merger and acquisition activity in the global pharmaceutical,…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Shire to acquire Lotus Tissue Repair for undisclosed price


Ireland-headquartered drugmaker Shire (LSE: SHP) said yesterday that it has signed an agreement to acquire…

BiotechnologyLotus Tissue RepairMergers & AcquisitionsPharmaceuticalRare diseasesShire

Big pharma will increasingly tap M&A to close $100 billion growth gap


Big pharma companies are facing a widening "growth gap" that will increase pressure to drive growth through…

BiotechnologyFinancialMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2012


Details for the 131 M&A announcements in 2012 recorded by The Pharma Letter are provided in the full…

BiotechGenericsMergers & AcquisitionsPharmaceutical

Evotec acquires Cell Culture Service GmbH; expands deal with AstraZeneca


German biotech firm Evotec (EVT: TecDAX) has acquired all the shares in Cell Culture Service GmbH (CCS),…

AstraZenecaBiotechnologyCell Culture Service GmbHDiabetesEvotecLicensingMedImmuneMergers & AcquisitionsPharmaceutical

Questcor Pharmaceuticals to acquire BioVectra for around $50 million


California, USA-based Questcor Pharmaceuticals (Nasdaq: QCOR) has signed a definitive agreement to acquire…

BiotechnologyBioVectraGenericsMergers & AcquisitionsPharmaceuticalProductionQuestor Pharmaceuticals

American Capital commits $212 million to acquire Cambridge Major Laboratories


Private equity firm American Capital (Nasdaq: ACAS) says that it has committed $212 million in the buyout…

American CapitalBiotechnologyCambridge Major LaboratoriesGenericsMergers & AcquisitionsPharmaceutical

Vivalis and Intercell announce "merger of equals"


French biotech firm Vivalis (Euronext: VLS) has entered into an accord to acquire Intercell (ICEL.VI)…

BiotechnologyIntercellMergers & AcquisitionsVaccinesValnevaVivalis

Enzon mulls sale of company; Bio-Rad to acquire business from MorphoSys


USA-based Enzon Pharmaceuticals (Nasdaq: ENZN) said yesterday that its board has retained Lazard to act…

Bio-Rad LaboratoriesBiotechnologyEnzon PharmaceuticalsMergers & AcquisitionsMorphoSys

Fresenius Kabi sells respiratory homecare business in France


Germany-based Fresenius Kabi, a provider of infusion therapy and clinical nutrition. has signed an agreement…

BiotechnologyFresenius BiotechFresenius KabiMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Gilead agrees to buy YM BioSciences for $510 million


US biotech firm Gilead Sciences (Nasdaq: GILD) has agreed to acquire Canada's YM BioSciences (TSX: YM)…

BiotechnologyCYT387Gilead SciencesMergers & AcquisitionsOncologyPharmaceuticalYM Biosciences

Amgen paying $415 to acquire deCODE Genetics


In what has been a busy M&A period for US biotech giant Amgen (Nasdaq: AMGN), the company has entered…

AmgenBiotechnologydeCODE GeneticsMergers & AcquisitionsPharmaceutical

Geron signs tentative deal with BioTime on stem cell assets


A year after announcing its decision to exit stem cell therapy, the USA's Geron Corp (Nasdaq: GERN) has…

BiotechnologyBioTimeFinancialGeron CorpMergers & Acquisitions

Synthetic Biologics to acquire clinical-stage C. diff infectious disease program


USA-based Synthetic Biologics (NYSE: SYN), a developer of synthetic biologics and innovative medicines…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsPrev AbRSYN-004Synthetic Biologics

Almirall expands in personalized medicine with 5% equity stake in AB-Biotics


Spain's largest pharma company Almirall (ALM.MC) says it has reached an agreement with the Spanish biotech…

AB-BioticsAlmirallBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

Pharmaceutical M&A activity declining slightly, reports Irving Levin Associates


A new five-and-a-half year pharmaceutical merger and acquisition report published by Irving Levin Associates…

BiotechnologyMergers & AcquisitionsPharmaceutical

Celgene in deal with PharmAria, including an acquisition option


Recently-formed drug discovery company PharmAria has entered into an agreement with US biotech firm Celgene…

BiotechnologyCelgeneMergers & AcquisitionsOncologyPharmAriaResearch

Australia's Benitec to acquire US RNAi firm Tacere


Australia-based Benitec Biopharma (ASX: BLT) said last Friday that it has executed an agreement to acquire…

Anti-viralsBenitec BiopharmaBiotechnologyMergers & AcquisitionsPharmaceuticalTacere Therapeutics

Optimer Pharma to sell remaining stake in Optimer Biotech for $60 million


San Diego, USA-based Optimer Pharmaceuticals (Nasdaq: OPTR) yesterday announced the sale of its stake…

BiotechnologyDificidMergers & AcquisitionsOptimer BiotechnologyOptimer PharmaceuticalsPharmaceutical

French drugmaker Aguettant takes majority stake in PX'Therapeutics


Aguettant Sante, a French biotechnology pioneer in drugs for injection since 1903, has acquired a majority…

AguettantBiotechnologyMergers & AcquisitionsPX'Therapeutics

176 to 200 of 271 results

Back to top